Fidelity International
KRTX

Fidelity International’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Fidelity International’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-59,885
Closed -$19M – 900
2023
Q4 		$19M Sell
59,885
-1,750
-3% -$340K 0.02% 425
2023
Q3 		$10.4M Sell
61,635
-6,506
-10% -$1.22M 0.01% 487
2023
Q2 		$14.8M Sell
68,141
-34,692
-34% -$7.43M 0.02% 449
2023
Q1 		$18.7M Buy
102,833
+67,274
+189% +$12.9M 0.02% 392
2022
Q4 		$6.99M Buy
+35,559
New +$7.62M 0.01% 535
2021
Q3 		– Sell
-16,491
Closed -$1.88M – 913
2021
Q2 		$1.88M Hold
16,491
– – ﹤0.01% 710
2021
Q1 		$1.98M Buy
16,491
+16,196
+5,490% +$1.83M ﹤0.01% 678
2020
Q4 		$30K Sell
295
-671,534
-100% -$62.2M ﹤0.01% 775
2020
Q3 		$51.9M Sell
671,829
-227,398
-25% -$19.4M 0.06% 275
2020
Q2 		$100M Buy
899,227
+278,715
+45% +$24.2M 0.14% 173
2020
Q1 		$44.7M Buy
620,512
+336,112
+118% +$28.7M 0.07% 247
2019
Q4 		$21.4M Sell
284,400
-259,298
-48% -$11.4M 0.03% 395
2019
Q3 		$8.87M Buy
543,698
+372,817
+218% +$7.24M 0.01% 490
2019
Q2 		$3.42M Buy
+170,881
New +$3.42M 0.01% 578

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Fidelity International's KRTX Position: Q1 2024 in Review

Fidelity International sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 59,885 shares — an estimated $19M sold.

Fidelity International first reported a position in KRTX in Q2 2019 and held it in 14 quarters. The position peaked at $100M in Q2 2020. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Fidelity International reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Fidelity International sold 59,885 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $19M.
  • Fidelity International first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2019 and held it in 14 quarters.
  • Fidelity International's Karuna Therapeutics, Inc. Common Stock position peaked at $100M in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Fidelity International's 13F filing for Q1 2024, filed 13 May 2024.